JPMorgan Chase & Co’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $297K | Sell |
54,342
-9,110
| -14% | -$49.8K | ﹤0.01% | 4283 |
|
|
2025
Q1 | $399K | Sell |
63,452
-158,212
| -71% | -$995K | ﹤0.01% | 4139 |
|
|
2024
Q4 | $913K | Buy |
221,664
+121,147
| +121% | +$499K | ﹤0.01% | 3854 |
|
|
2024
Q3 | $336K | Buy |
100,517
+69,167
| +221% | +$231K | ﹤0.01% | 4231 |
|
|
2024
Q2 | $93.4K | Buy |
31,350
+5,887
| +23% | +$17.5K | ﹤0.01% | 4622 |
|
|
2024
Q1 | $87.8K | Sell |
25,463
-1,520
| -6% | -$5.24K | ﹤0.01% | 4783 |
|
|
2023
Q4 | $36.2K | Sell |
26,983
-2
| -0% | -$3 | ﹤0.01% | 5109 |
|
|
2023
Q3 | $58.8K | Sell |
26,985
-6,189
| -19% | -$13.5K | ﹤0.01% | 4846 |
|
|
2023
Q2 | $79.3K | Buy |
+33,174
| New | +$79.3K | ﹤0.01% | 4730 |
|
|
2020
Q4 | – | Sell |
-3
| Closed | – | – | 5095 |
|
|
2020
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 5021 |
|
|
2020
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 4963 |
|